Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial

被引:80
作者
Cladder-Micus, Mira B. [1 ,2 ,3 ]
Speckens, Anne E. M. [3 ]
Vrijsen, Janna N. [2 ,4 ]
Donders, A. Rogier T. [5 ]
Becker, Eni S. [1 ]
Spijker, Jan [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands
[2] Pro Persona Mental Hlth Care, Depress Expertise Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, POB 9101,Internal Postal Code 966, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Dept Psychiat, Donders Inst Brain Cognit & Behav, Med Ctr, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands
关键词
depressive disorder; mindfulness; quality of life; randomized controlled trial; treatment-resistant depression; BEHAVIORAL ANALYSIS SYSTEM; MAUDSLEY STAGING METHOD; PSYCHOMETRIC PROPERTIES; GROUP VERSION; PSYCHOTHERAPY; EFFICACY; RELAPSE; QUESTIONNAIRE; REPLICATION; POPULATION;
D O I
10.1002/da.22788
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
BackgroundChronic and treatment-resistant depressions pose serious problems in mental health care. Mindfulness-based cognitive therapy (MBCT) is an effective treatment for remitted and currently depressed patients. It is, however, unknown whether MBCT is effective for chronic, treatment-resistant depressed patients. MethodA pragmatic, multicenter, randomized-controlled trial was conducted comparing treatment-as-usual (TAU) with MBCT + TAU in 106 chronically depressed outpatients who previously received pharmacotherapy (4weeks) and psychological treatment (10 sessions). ResultsBased on the intention-to-treat (ITT) analysis, participants in the MBCT + TAU condition did not have significantly fewer depressive symptoms than those in the TAU condition (-3.23 [-6.99 to 0.54], d=0.35, P=0.09) at posttreatment. However, compared to TAU, the MBCT + TAU group reported significantly higher remission rates ((2)(2)=4.25, =0.22, P=0.04), lower levels of rumination (-3.85 [-7.55 to -0.15], d=0.39, P=0.04), a higher quality of life (4.42 [0.03-8.81], d=0.42, P=0.048), more mindfulness skills (11.25 [6.09-16.40], d=0.73, P<0.001), and more self-compassion (2.91 [1.17-4.65], d=0.64, P=0.001). The percentage of non-completers in the MBCT + TAU condition was relatively high (n=12, 24.5%). Per-protocol analyses revealed that those who completed MBCT + TAU had significantly fewer depressive symptoms at posttreatment compared to participants receiving TAU (-4.24 [-8.38 to -0.11], d=0.45, P=0.04). ConclusionAlthough the ITT analysis did not reveal a significant reduction in depressive symptoms of MBCT + TAU over TAU, MBCT + TAU seems to have beneficial effects for chronic, treatment-resistant depressed patients in terms of remission rates, rumination, quality of life, mindfulness skills, and self-compassion. Additionally, patients who completed MBCT showed significant reductions in depressive symptoms. Reasons for non-completion should be further investigated.
引用
收藏
页码:914 / 924
页数:11
相关论文
共 50 条
  • [1] A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
    Eisendrath, Stuart J.
    Gillung, Erin
    Delucchi, Kevin L.
    Segal, Zindel V.
    Nelson, J. Craig
    McInnes, L. Alison
    Mathalon, Daniel H.
    Feldman, Mitchell D.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (02) : 99 - 110
  • [2] Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression
    Cladder-Micus, Mira B.
    Vrijsen, Janna N.
    Fest, Antine
    Spijker, Jan
    Donders, A. Rogier T.
    Becker, Eni S.
    Speckens, Anne E. M.
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 335 : 410 - 417
  • [3] A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol
    Cladder-Micus, Mira B.
    Vrijsen, Janna N.
    Becker, Eni S.
    Donders, Rogier
    Spijker, Jan
    Speckens, Anne E. M.
    BMC PSYCHIATRY, 2015, 15
  • [4] Effects of Mindfulness-Based Cognitive Therapy on a Behavioural Measure of Rumination in Patients with Chronic, Treatment-Resistant Depression
    Cladder-Micus, Mira B.
    Becker, Eni S.
    Spijker, Jan
    Speckens, Anne E. M.
    Vrijsen, Janna N.
    COGNITIVE THERAPY AND RESEARCH, 2019, 43 (04) : 666 - 678
  • [5] A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol
    Mira B. Cladder-Micus
    Janna N. Vrijsen
    Eni S. Becker
    Rogier Donders
    Jan Spijker
    Anne E. M. Speckens
    BMC Psychiatry, 15
  • [6] Online mindfulness-based cognitive therapy for treatment-resistant depression: a parallel-arm randomized controlled feasibility trial
    Rodrigues, Michele Ferreira
    Quagliato, Laiana
    Appolinario, Jose Carlos
    Nardi, Antonio E.
    FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [7] Adapting Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
    Eisendrath, Stuart
    Chartier, Maggie
    McLane, Maura
    COGNITIVE AND BEHAVIORAL PRACTICE, 2011, 18 (03) : 362 - 370
  • [8] Mindfulness-based cognitive group therapy for treatment-refractory anxiety disorder: A pragmatic randomized controlled trial
    Spinhoven, Philip
    Hoogerwerf, Elena
    van Giezen, Anne
    Greeven, Anja
    JOURNAL OF ANXIETY DISORDERS, 2022, 90
  • [9] Effects of Mindfulness-Based Cognitive Therapy on a Behavioural Measure of Rumination in Patients with Chronic, Treatment-Resistant Depression
    Mira B. Cladder-Micus
    Eni S. Becker
    Jan Spijker
    Anne E. M. Speckens
    Janna N. Vrijsen
    Cognitive Therapy and Research, 2019, 43 : 666 - 678
  • [10] Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial
    Kuelz, Anne Katrin
    Landmann, Sarah
    Cludius, Barbara
    Rose, Nina
    Heidenreich, Thomas
    Jelinek, Lena
    Alsleben, Heike
    Wahl, Karina
    Philipsen, Alexandra
    Voderholzer, Ulrich
    Maier, Jonathan G.
    Moritz, Steffen
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (02) : 223 - 233